# Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy

> **NCT03542006** · PHASE2 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 35 (estimated)

## Conditions studied

- Central Serous Chorioretinopathy

## Interventions

- **DRUG:** Brinzolamide Ophthalmic

## Key facts

- **NCT ID:** NCT03542006
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2019-01-01
- **Final completion:** 2019-04-01
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2018-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03542006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03542006, "Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03542006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*